MTOR and neoplasm: At mechanistic level, tumor growth impairment was coupled with a decrease in cyclin B1, Rb, Foxm1, Plk1 and phosphorylation of the ribosomal protein S6, a protein phosphorylated by the mTOR pathway and tightly associated with cell cycle progression (90).